Regeneron halts trial of antibody treatment in seriously ill Covid patients Financial TimesRegeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients | TheHill The HillTrial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients The Wall Street Journal2nd study testing a COVID-19 antibody drug has a setback NBC MontanaRegeneron stops enrolling critically ill COVID-19 patients for antibody drug trial | TheHill The HillView Full Coverage on Google News